Brief: Century Therapeutics Announces Presentation Of Data At 63Rd American Society Of Hematology Annual Meeting And Provides Pipeline Updates
16/12/2021 12:12
Dec 16 (Reuters) - Century Therapeutics Inc IPSC.O :
* CENTURY THERAPEUTICS ANNOUNCES PRESENTATION OF DATA AT
63RD
AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING AND PROVIDES
PIPELINE UPDATES
* CENTURY THERAPEUTICS- ANNOUNCES PLANS FOR PHASE 1 ELIPSE-1
TRIAL
OF CNTY-101 IN RELAPSED/REFRACTORY LYMPHOMA; IND SUBMISSION ON
TRACK FOR MID-2022
Source text for Eikon: ID:nGNX3RJ8l8
Further company coverage: IPSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview